- AU$217.65m
- AU$200.61m
- NZ$103.85m
Australia Stock Exchange release from AROA BIOSURGERY : Change of Director's Interest Notice - JD
Australia Stock Exchange release from AROA BIOSURGERY : Application for quotation of securities - ARX
Australia Stock Exchange release from AROA BIOSURGERY : Section 708A Notice
Australia Stock Exchange release from AROA BIOSURGERY : Revised Securities Dealing Policy
Australia Stock Exchange release from AROA BIOSURGERY : December Quarterly Report and Appendix 4C
Australia Stock Exchange release from AROA BIOSURGERY : PRE_NR Ends: 08:43:13
Australia Stock Exchange release from AROA BIOSURGERY : Notification of Quarterly Webinar
Australia Stock Exchange release from AROA BIOSURGERY : Notification of cessation of securities - ARX
Australia Stock Exchange release from AROA BIOSURGERY : Application for quotation of securities - ARX
Australia Stock Exchange release from AROA BIOSURGERY : Section 708A Notice
Brief: Aroa Biosurgery Says HY Loss After Tax Attributable NZ$5.1 Mln
Australia Stock Exchange release from AROA BIOSURGERY : Aroa Biosurgery Half Yearly Report Update Amendment
Australia Stock Exchange release from AROA BIOSURGERY : Aroa Biosurgery Half Yearly Report H1 FY21
Australia Stock Exchange release from AROA BIOSURGERY : PRE_NR Ends: 08:43:46
Australia Stock Exchange release from AROA BIOSURGERY : Appendix 4D and Half Year Report
Australia Stock Exchange release from AROA BIOSURGERY : PRE_NR Ends: 08:38:51
Australia Stock Exchange release from AROA BIOSURGERY : New study extends understanding of AROA ECM
Australia Stock Exchange release from AROA BIOSURGERY : Bell Potter Healthcare Conference Presentation - Nov 2021
ASX-listed Aroa Biosurgery jumps on upbeat results, forecast hike